Stay updated on Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer text now includes Moffitt center branding and a new revision tag (v3.6.3). The old revision tag (v3.6.2) was removed.
    Difference
    0.2%
    Check dated 2026-07-04T13:13:06.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.2 from v3.6.0, signaling a new version of the page metadata. This update reflects documentation/version control activity rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-06-27T06:39:51.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Recruitment status now indicates no participant enrollment; new sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading was adjusted with a revision note updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T00:30:49.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.5.4 to v3.5.5, indicating a new build/version of the page. This is a minor metadata change that does not alter visible content or functionality.
    Difference
    0.0%
    Check dated 2026-06-05T23:52:05.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Sponsor attribution and the credits label are removed from the study page, altering how the page credits its sponsor and provides external links.
    Difference
    0.1%
    Check dated 2026-05-29T23:47:41.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the page, replacing the previous v3.5.3. This represents a small metadata update indicating a new publication revision.
    Difference
    0.0%
    Check dated 2026-05-15T15:31:43.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.